SEC Tracker
Get the app

Kymera Therapeutics KYMR

Bruce N. Jacobs (Officer) plans to sell 3,934 KYMR shares, about $171,129

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Mar 4, 2024
  2. Broker: Morgan Stanley Smith Barney LLC
  3. Shares acquired by: Shares acquired upon vesting of Restricted Stock Units awarded under the Issuer's 2020 Equity Incentive Plan.

All of Bruce N. Jacobs's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 2,378 shares at $41.41 on Mar 4, 2024 · Form 4
  • Sold 1,301 shares at $42.39 on Mar 4, 2024 · Form 4
  • Sold 255 shares at $43.26 on Mar 4, 2024 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Kymera Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Acadia Pharmaceuticals ACAD public float $2.3B, Jun 30, 2025
  2. Twist Bioscience TWST public float $2.3B, Mar 31, 2025, over 18 months old
  3. Xenon Pharmaceuticals XENE public float $2.4B, Jun 30, 2025
  4. Summit Therapeutics SMMT public float $2.5B, Jun 30, 2025
  5. Cytokinetics CYTK public float $2.5B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.